Alternatives
Alternatives to WeightCare
WeightCare scores 72/100 on our Cost-Efficiency Index . Here are other programs to consider, each scored the same way. Partners are listed first.
WeightCare at a glance
- Semaglutide
- $399/moAll doses, monthly plan, compounded; $249/mo on a 3-month plan, $215/mo on 6 months, $139/mo on 12 months
- Tirzepatide
- $499/moAll doses, monthly plan, compounded; $216/mo on a 12-month plan at any dose; the 3- and 6-month plans, $299/mo and $275/mo, stop at 7.5 mg
- Coverage
- 46 states
- Brand-name GLP-1s
- No, compounded only
- Oral option
- No
- Pricing verified
- October 2026
7 of the 8 programs below list semaglutide for less than WeightCare's $399 a month. 6 of the 8 list tirzepatide for less than its $499 a month.
WeightCare sells compounded semaglutide and tirzepatide by telehealth in 46 states, month to month at $399 and $499 or for less per month on 3-, 6- and 12-month plans.
Best for: Shoppers who want a no-commitment monthly plan that covers every dose, with the option to lock in a much lower rate on a 12-month plan.
What WeightCare does well
- True month-to-month plans with no commitment, covering every dose of both drugs
- 12-month plans bring the price down to $139/mo for semaglutide and $216/mo for tirzepatide at any dose
- Serves 46 states (all but Alaska, Hawaii, Louisiana and Mississippi)
- Cancel anytime in your account or by email, with a reminder 7 days before every renewal charge
- PCAB-accredited, FDA-registered compounding pharmacies claimed, though not named
Why readers look for an alternative
- The 3- and 6-month tirzepatide plans stop at 7.5 mg a week; higher doses need a separate high-dose plan ($358–$450/mo)
- Canceling stops future charges only: time already billed isn't pro-rated, and refunds are generally not available once your medical questionnaire is in
- The semaglutide page also excludes Alabama
- No LegitScript certification, and no named medical director, prescriber or compounding pharmacy
- FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026; the letter is public in FDA's warning-letter database
- Partner01A94/ 100Index
CoreAge Rx
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
- Brand
- Compounded
Compared with WeightCare: $300/mo less for semaglutide · $350/mo less for tirzepatide
- 02C73/ 100Index
Maximus
Maximus sells compounded tirzepatide at one flat rate for every dose, from $249.99 a month on its shortest two-month plan down to $149.99 on a 12-month plan, each billed up front.
- Sema
- Not offered
- Tirz
- $249.99/mo2-month plan, billed up front, compounded
- Coverage
- 47 states
- Brand
- Yes
Compared with WeightCare: $250/mo less for tirzepatide · also lists brand-name GLP-1s · offers an oral option
Regulatory note: the FDA issued a warning letter to Maximus Health, Inc. dba Maximus in June 2026. We still list and link to Maximus; you should know the letter is on the public record before you decide.
- 03C72/ 100Index
Amazon One Medical
Amazon One Medical's GLP-1 program prescribes brand-name drugs only, never compounded ones, and charges a separate ~$39 initial care fee on top of the medication.
- Sema
- $149/moBrand Wegovy pill starting dose with manufacturer coupon if eligible; plus a separate fee for care visits
- Tirz
- Not disclosed
- Coverage
- All 50 states
- Brand
- Yes
Compared with WeightCare: $250/mo less for semaglutide · also lists brand-name GLP-1s · offers an oral option
- 04C72/ 100Index
Get Thin MD
Get Thin MD (GetThinUSA) is a nationwide-advertised telehealth platform selling compounded semaglutide and tirzepatide (plus brand Ozempic/Zepbound) alongside a broader wellness menu.
- Sema
- $119/moStarting dose, compounded
- Tirz
- $179/moStarting dose, compounded
- Coverage
- All 50 states
- Brand
- Yes
Compared with WeightCare: $280/mo less for semaglutide · $320/mo less for tirzepatide · also lists brand-name GLP-1s
- 05C72/ 100Index
Revel RX
Revel RX is a telehealth GLP-1 platform selling compounded semaglutide and tirzepatide at one flat monthly price per drug regardless of dose $89 and $155 with online consultation and 2-day shipping already included and no membership fee.
- Sema
- $89/moAll doses, compounded
- Tirz
- $155/mo
- Coverage
- Multi-state
- Brand
- Compounded
Compared with WeightCare: $310/mo less for semaglutide · $344/mo less for tirzepatide
- 06C72/ 100Index
HeliMeds
HeliMeds sells compounded injections as one-time purchases with no automatic renewal. A one-month refill is $225 for semaglutide or $285 for tirzepatide; introductory and prepaid orders differ.
- Sema
- $225One-month refill (compounded; first one-month order $175)
- Tirz
- $285One-month refill (compounded; first one-month order $235)
- Coverage
- Multi-state
- Brand
- Yes
Compared with WeightCare: $174/mo less for semaglutide · $214/mo less for tirzepatide · also lists brand-name GLP-1s
- 07C72/ 100Index
Allara Health
Allara Health is an insurance-accepting telehealth platform for women's hormonal and metabolic health (including PCOS), prescribing FDA-approved brand GLP-1s (Wegovy, Zepbound) among other treatments.
- Sema
- $149/moPlus a separate fee, brand-name
- Tirz
- Not disclosed
- Coverage
- 45 states + DC
- Brand
- Yes
Compared with WeightCare: $250/mo less for semaglutide · also lists brand-name GLP-1s · offers an oral option
- 08C72/ 100Index
Medro
Medro is a telehealth brand launched in 2026 that sells compounded semaglutide at $199 a month and tirzepatide at $299 a month, with $99 off the first plan and no membership fee.
- Sema
- $199/moMonthly plan, compounded; first month $99
- Tirz
- $299/moMonthly plan, compounded; first month $199
- Coverage
- All 50 states
- Brand
- Compounded
Compared with WeightCare: $200/mo less for semaglutide · $200/mo less for tirzepatide
Assume any provider we list may compensate us — it never changes the Cost-Efficiency Index. Pricing and coverage reflect public disclosures at last review; confirm on each provider's site. Not medical advice. See our disclosure.